J&J Medtech Sales Disappoint, Considers Orthopedic Spinoff
Bloomberg Television · 1:49
Johnson & Johnson shares fell in premarket trading even though the company raised its profit guidance. The pharmaceutical side did well, but weaker-than-expected medical device sales took the focus, and J&J also said...